MCU and gastric cancer: Notably, elevated MCU expression has been reported in gastric cancer and is associated with poor clinical outcomes due to its impact on oxidative phosphorylation, the NAD+–NADH balance, the tricarboxylic acid cycle, and overall metabolic function [31].